The global Endometrial Ablation market was valued at USD 985.8 Mn in 2017 and is expected to reach USD 1,588.3 Mn by 2026, expanding at a CAGR of 5.3% from 2018 to 2026.
Market Insights:
Endometrial ablation is considered the most effective minimally invasive procedure to treat abdominal uterine bleeding in some cases compared to hysterectomy or other medical treatments. It is efficiently replacing resectoscopic ablation technologies specifically for abdominal uterine bleeding. However, a resectoscope is still essential for the treatment of sub-mucosal fibroids, adenomyoma, large polyps, and Mullerian anomaly among others. There are some novel technologies that are expected to assist the market growth in the near future such as Minerva (Argon-bipolar technology), Cryotherapy, Aegea (Low-Pressure Vapor), and Lina Librata (Glycerine-filled Balloon). The key advantages possessed by endometrial ablation are a lower rate of serious side-effects, and post-surgery hospitalization. Endometrial ablation device market faces challenges such as low treatment access, lack of trained physicians, and noticeable failure rates.
Radiofrequency endometrial ablation devices accounted for the largest share of around 55% due to key market driving factors such as high safety & fast recovery, increasing awareness related to this technique in developing countries, and high preference from several medical practitioners. On November 19, 2014, Hologic had launched NovaSure for the treatment of abnormal uterine bleeding and it’s was effectively accepted in the market by many surgeons, cost-efficiency & quick patient recovery has been key advantages assisting overall growth of NovaSure.
North America was identified as the largest endometrial ablation market in the year 2017 attributing to the overwork & sedentary lifestyle in women that assists prevalence of abnormal uterine bleeding and increasing awareness related to uterine bleeding & complexities associated with post-endometrial ablation surgeries. The Asia Pacific will maintain its dominance throughout the forecast period from 2018 to 2026 due to key driving factors such as increasing accessibility & availability of novel endometrial ablation devices and rising public awareness related to abnormal uterine bleeding and other complexities.
Market Competition Assessment:
The growth of endometrial ablation is at a significant pace and key companies operating in this market are focusing on the development of safe & efficient endometrial ablation devices. The major market players in this market are Boston Scientific Corporation, Olympus Corporation, Hologic Corporation, Smith & Nephew plc, Minerva Surgical, Inc., KARL STORZ GmbH & Co. KG, The Cooper Companies, Inc., Medtronic plc, Richard Wolf GmbH, Ethicon, Inc., AngioDynamics Inc. among others.
Key Market Movements:
This product will be delivered within 2 business days.
Market Insights:
Endometrial ablation is considered the most effective minimally invasive procedure to treat abdominal uterine bleeding in some cases compared to hysterectomy or other medical treatments. It is efficiently replacing resectoscopic ablation technologies specifically for abdominal uterine bleeding. However, a resectoscope is still essential for the treatment of sub-mucosal fibroids, adenomyoma, large polyps, and Mullerian anomaly among others. There are some novel technologies that are expected to assist the market growth in the near future such as Minerva (Argon-bipolar technology), Cryotherapy, Aegea (Low-Pressure Vapor), and Lina Librata (Glycerine-filled Balloon). The key advantages possessed by endometrial ablation are a lower rate of serious side-effects, and post-surgery hospitalization. Endometrial ablation device market faces challenges such as low treatment access, lack of trained physicians, and noticeable failure rates.
Radiofrequency endometrial ablation devices accounted for the largest share of around 55% due to key market driving factors such as high safety & fast recovery, increasing awareness related to this technique in developing countries, and high preference from several medical practitioners. On November 19, 2014, Hologic had launched NovaSure for the treatment of abnormal uterine bleeding and it’s was effectively accepted in the market by many surgeons, cost-efficiency & quick patient recovery has been key advantages assisting overall growth of NovaSure.
North America was identified as the largest endometrial ablation market in the year 2017 attributing to the overwork & sedentary lifestyle in women that assists prevalence of abnormal uterine bleeding and increasing awareness related to uterine bleeding & complexities associated with post-endometrial ablation surgeries. The Asia Pacific will maintain its dominance throughout the forecast period from 2018 to 2026 due to key driving factors such as increasing accessibility & availability of novel endometrial ablation devices and rising public awareness related to abnormal uterine bleeding and other complexities.
Market Competition Assessment:
The growth of endometrial ablation is at a significant pace and key companies operating in this market are focusing on the development of safe & efficient endometrial ablation devices. The major market players in this market are Boston Scientific Corporation, Olympus Corporation, Hologic Corporation, Smith & Nephew plc, Minerva Surgical, Inc., KARL STORZ GmbH & Co. KG, The Cooper Companies, Inc., Medtronic plc, Richard Wolf GmbH, Ethicon, Inc., AngioDynamics Inc. among others.
Key Market Movements:
- Increasing demand for minimally invasive endometrial ablation is expected to assist the future market growth
- Mounting prevalence of gynecological disorders is also assisting the awareness related to an availability of treatments
- Technologically endometrial ablation devices are developing focusing specifically on the efficiency and swift recovery
- A few recalls related with endometrial ablation devices has been one of the key restraints restricting the market growth "
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Preface1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Endometrial Ablation Devices Market Portraiture
2.2. Global Endometrial Ablation Devices Market, by Type of Device, 2017 (US$ Mn)
2.3. Global Endometrial Ablation Devices Market, by End-User, 2017 (US$ Mn
2.4. Global Endometrial Ablation Devices Market, by Geography, 2017 Vs 2026 (Value %)
Chapter 3. Global Endometrial Ablation Devices Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.2.1. Increasing prevalence of menorrhagia and other menstrual disorders
3.2.2. Technological development coupled with supportive reimbursement policies
3.3. Challenges
3.3.1. Stringent regulatory policies have increased the rate of product recall
3.4. Opportunities
3.4.1. Increasing market penetration in developing economies expected to meet the unmet needs in the near future
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2017
Chapter 4. Global Endometrial Ablation Devices Market, by Type of Device, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Hysteroscopy Devices
4.3. Radiofrequency Endometrial Ablation Devices
4.4. Thermal Balloon Ablation Devices
4.5. Hydrothermal Ablation Devices
4.6. Microwave Endometrial Ablation Devices
4.7. Cryoablation Devices
4.8. Electrical Ablation Devices
Chapter 5. Global Endometrial Ablation Devices Market, by End-Users, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Hospitals
5.3. Ambulatory Surgical Centers
5.4. Clinics
Chapter 6. Global Endometrial Ablation Devices Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America Endometrial Ablation Devices Market Analysis, 2016 – 2026
6.2.1. North America Endometrial Ablation Devices Market, by Type of Device, 2016–2026 (US$ Mn)
6.2.2. North America Endometrial Ablation Devices Market, by End-Users, 2016–2026 (US$ Mn)
6.2.3. North America Endometrial Ablation Devices Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Endometrial Ablation Devices Market Analysis, 2016 – 2026
6.3.1. Europe Endometrial Ablation Devices Market, by Type of Device, 2016–2026 (US$ Mn)
6.3.2. Europe Endometrial Ablation Devices Market, by End-Users, 2016–2026 (US$ Mn)
6.3.3. Europe Endometrial Ablation Devices Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Endometrial Ablation Devices Market Analysis, 2016 – 2026
6.4.1. Asia Pacific Endometrial Ablation Devices Market, by Type of Device, 2016–2026 (US$ Mn)
6.4.2. Asia Pacific Endometrial Ablation Devices Market, by End-users, 2016–2026 (US$ Mn)
6.4.3. Asia Pacific Endometrial Ablation Devices Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America Endometrial Ablation Devices Market Analysis, 2016 – 2026
6.5.1. Latin America Endometrial Ablation Devices Market, by Type of Device, 2016–2026 (US$ Mn)
6.5.2. Latin America Endometrial Ablation Devices Market, by End-Users, 2016–2026 (US$ Mn)
6.5.3. Latin America Endometrial Ablation Devices Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Endometrial Ablation Devices Market Analysis, 2016 – 2026
6.6.1. Middle East & Africa Endometrial Ablation Devices Market, by Type of Device, 2016–2026 (US$ Mn)
6.6.2. Middle East & Africa Endometrial Ablation Devices Market, by End-Users, 2016–2026 (US$ Mn)
6.6.3. MEA Endometrial Ablation Devices Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. Hologic Corporation
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Boston Scientific Corporation
7.3. Olympus Corporation
7.4. Minerva Surgical, Inc.
7.5. Smith & Nephew plc
7.6. The Cooper Companies
7.7. KARL STORZ GmbH & Co. KG
7.8. Richard Wolf GmbH
7.9. Ethicon, Inc.
7.10. Medtronic plc
7.11. AngioDynamics Inc.
List of Figures
FIG. 1 Endometrial Ablation Devices: Market Segmentation
FIG. 2 Global Endometrial Ablation Devices Market Share, by Type of Device, 2017 (US$ Mn)
FIG. 3 Global Endometrial Ablation Devices Market Share, by End-Users, 2017 (US$ Mn)
FIG. 4 Global Endometrial Ablation Devices Market, by Geography, 2017 Vs 2026 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography, 2017
FIG. 6 Market Competition Landscape, by Key Players, 2017
FIG. 7 Global Hysteroscopy Devices Market, 2016 – 2026 (US$ Mn)
FIG. 8 Global Radiofrequency Endometrial Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 9 Global Thermal Balloon Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 10 Global Hydrothermal Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 11 Global Microwave Endometrial Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 12 Global Cryoablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 13 Global Electrical Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 14 Global Endometrial Ablation Market for Hospitals, 2016 – 2026 (US$ Mn)
FIG. 15 Global Endometrial Ablation Market for Ambulatory Surgical Centers, 2016 – 2026 (US$ Mn)
FIG. 16 Global Endometrial Ablation Market for Clinics, 2016 – 2026 (US$ Mn)
FIG. 17 U.S. Endometrial Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 18 Canada Endometrial Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 19 U.K. Endometrial Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 20 Germany Endometrial Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 21 Rest Of Europe Endometrial Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 22 Japan Endometrial Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 23 China Endometrial Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 24 Rest Of Asia Pacific Endometrial Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 25 Brazil Endometrial Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 26 Mexico Endometrial Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 27 Rest Of Latin America Endometrial Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 28 GCC Endometrial Ablation Devices Market, 2016 – 2026 (US$ Mn)
FIG. 29 Rest Of Middle East And Africa Endometrial Ablation Devices Market, 2016 – 2026 (US$ Mn)List of Tables
TABLE 1 Global Endometrial Ablation Devices Market, by Type of Devices, 2016 – 2026 (US$ Mn)
TABLE 2 Global Endometrial Ablation Devices Market, by End-Users, 2016 – 2026 (US$ Mn)
TABLE 3 North America Endometrial Ablation Devices Market, by Type of Device, 2016 – 2026 (US$ Mn)
TABLE 4 North America Endometrial Ablation Devices Market, by End-Users, 2016 – 2026 (US$ Mn)
TABLE 5 North America Endometrial Ablation Devices Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 6 Europe Endometrial Ablation Devices Market, by Type of Device, 2016 – 2026 (US$ Mn)
TABLE 7 Europe Endometrial Ablation Devices Market, by End-Users, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Endometrial Ablation Devices Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 9 Asia Pacific Endometrial Ablation Devices Market, by Type of Device, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific Endometrial Ablation Devices Market, by End-Users, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Endometrial Ablation Devices Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 Latin America Endometrial Ablation Devices Market, by Type of Device, 2016 – 2026 (US$ Mn)
TABLE 13 Latin America Endometrial Ablation Devices Market, by End-Users, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America Endometrial Ablation Devices Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 15 Middle East & Africa Endometrial Ablation Devices Market, by Type of Device, 2016 – 2026 (US$ Mn)
TABLE 16 Middle East & Africa Endometrial Ablation Devices Market, by End-Users, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East And Africa Endometrial Ablation Devices Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 18 Hologic Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 Boston Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Olympus Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Minerva Surgical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Smith & Nephew plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 The Cooper Companies: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 KARL STORZ GmbH & Co. KG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Richard Wolf GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Ethicon, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Medtronic plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 AngioDynamics Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Companies Mentioned
- Hologic Corporation
- Boston Scientific Corporation
- Olympus Corporation
- Minerva Surgical, Inc.
- Smith & Nephew plc
- The Cooper Companies
- KARL STORZ GmbH & Co. KG
- Richard Wolf GmbH
- Ethicon, Inc.
- Medtronic plc
- AngioDynamics Inc.
